Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis.
Saved in:
| Title: | Telitacicept as a BAFF/APRIL dual inhibitor: efficacy and safety in reducing proteinuria for refractory childhood IgA vasculitis nephritis. |
|---|---|
| Authors: | Jin, Yanyan1, Zhu, Jianhong2, Sheng, Aiqin1, Lin, Qian1, Zhao, Manli3, He, Xue1, Mao, Jianhua1, Fu, Haidong1 chfhd@zju.edu.cn |
| Source: | Pediatric Nephrology. Aug2025, Vol. 40 Issue 8, p2561-2569. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
